AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
May 12, 2015
29821_dirs_2015-05-12_69325ac1-8cb9-4c92-bf83-5e59dee2f37d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-05-11
Reporting Person: Sorenson John Bradley (SVP, Manuf & Sup Chn)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-11 | Common Stock | M | 8735.0000 | $7.1600 | Acquired | 22222.0000 | Direct |
| 2015-05-11 | Common Stock | S | 8735.0000 | $17.4938 | Disposed | 13487.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-11 | Stock Option (Right to Buy) | $7.1600 | M | 8735.0000 | Disposed | 2021-02-28 | Common Stock (8735.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.42 to $17.56, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.